reMARQable v3.1
Research type
Research Study
Full title
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
IRAS ID
145819
Contact name
Ghulam André Ng
Contact email
Clinicaltrials.gov Identifier
Research summary
The Main Study will consist of a prospective, multi-center, randomized(1:1 concurrent nMARQ™ technology System [nMARQ] vs THERMOCOOL® Navigational Family of catheters [TC]), controlled, two arm,single-blind design. Embedded within the Main Study will be a Subpopulation Neurological Assessment (SNA) with a prospective,
controlled design, with consecutive enrollment. Main objective is to demonstrate safety and effectiveness of nMARQ™ technology [nMARQ] compared with THERMOCOOL® Navigational Family of catheters in treating subjects with drug-refractory symptomatic paroxysmal atrial fibrillation (PAF).REC name
Yorkshire & The Humber - Sheffield Research Ethics Committee
REC reference
14/YH/0141
Date of REC Opinion
24 Jun 2014
REC opinion
Further Information Favourable Opinion